Blood glucose monitoring devices
market is very lucrative business with enormous future potential.
Self-monitoring blood glucose market is primarily dependent on number of
diabetic patients. So with the growth in diabetic patients blood glucose
monitoring devices market is set to grow many folds. By the end of 2013 there
was 382 Million people suffering from diabetes and this figure is expect to
rise further to 592 Million by 2035.

For the year 2013 Self-monitoring
blood glucose (SMBG) users has grown more than 50% from the number of users in
2007. China has the highest number of self-monitoring blood glucose device
users but United States has highest number of test strips market share. Although
self-monitoring blood glucose devices market is expected to grow with single
digit CAGR, but its market is in double digit Billion US$. United States
controls the highest market share in the self-monitoring blood glucose (SMBG)
market worldwide. 4 companies Roche Diagnostic, LifeScan Inc., Bayer
HealthCare and Abbott Laboratories together controls nearly 50% market share
of self-monitoring blood glucose devices.